PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.\', \'Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.\', \'University Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany.\', \'Institute of Animal Pathology, COMPATH, University of Bern, Bern, Switzerland.\', \'Histology Core Facility, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.\', \'Institute of Pathology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.\', \'Division of Pulmonology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.\', \'Biological Electron Microscopy Facility, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.\', \'Department of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland. michel.gilliet@chuv.ch.\', \'Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. andrea.ablasser@epfl.ch.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41586-022-04421-w
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 35045565
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all